期刊文献+

新型MR造影剂钆贝葡胺诊断肝脏局灶性结节样增生的价值(附5例报告) 被引量:7

Value of Gd-BOPTA Enhanced MR Imaging in Diagnosing Focal Nodular Hyperplasia of Liver (Report of 5 Cases)
下载PDF
导出
摘要 目的探讨具有双相作用的新型磁共振造影剂钆贝葡胺(Gd-BOPTA)应用于肝脏局灶性结节样增生(focal nodular hyperplasia,FNH)的MR表现及其病理基础。方法对5例临床及影像检查怀疑为FNH的患者(共6个病灶),按以下顺序分别行MRI常规轴位的T2W和T1W平扫、冠状位T2加权图像、3D磁共振胆胰管成像(MRCP)、Gd-BOPTA增强的轴位LAVA三期动态扫描(扫描延时时间为15、55及90s)、2D-T1W增强扫描、LAVA延时扫描(5及10min)及肝胆期扫描(40及80min)。收集大体标本及病理切片,与磁共振各序列表现进行对比分析。结果5例6个病灶均诊断正确(5个手术证实,1个穿刺证实)。血液动力学期(动态期):5个FNH病灶实质部分动脉期强化明显,门脉期及延迟期强化减弱呈等或稍低信号,另1个病灶除动脉期轻度强化外,门脉期及延迟期均呈等信号;5个中央疤痕动脉期及门脉期无强化,而延迟期均强化。②肝胆期(排泄期):6个病灶实质部分呈稍高或等信号,其中1个肿块中可见高信号的树枝样胆管;中央疤痕均呈稍低信号。③病理:FNH实质为正常肝细胞团呈不规则排列,伴有不同程度肝细胞水肿及淤胆改变,且均存在汇管区缺失;疤痕为大量纤维组织,内有厚壁动脉血管、增生胆管及炎性细胞浸润,部分伴有少许黏液变性。结论Gd-BOPTA作为一种双相(既能反映血液动力学特性又能被肝细胞特异性摄取)作用的造影剂,Gd-BOPTA增强MR检查能准确反映FNH的病理特点。 Objective To investigate the value of a new double action MR contrast agent Gd-BOPTA in the diagnosis of focal nodular hyperplasia (FNH) of the liver with correlation of pathology. Methods Dedicated MRI scans were performed for 5 patients suspected to have liver FNH on clinical and imaging basis (six lesions). The MR imaging protocol included axial T1W and T2W plain scan, coronal T2 weighted imaging, 3D MRCP, Gd- BOPTA enhanced LAVA dynamic tri-phasic acquisitions (scanning at 15 s, 55 s and 90 s respectively), enhanced 2D T1W scan, enhanced LAVA in delay phase (at 5 and 10 min) and in the hepatobiliary phase (at 40 and 80 min). The imaging features on each MR sequence were compared with surgical and pathological findings. Results Six le- sions in 5 FNH patients were all correctly diagnosed (5 conformed by surgery and 1 by needle biopsy). ①The hemodynamic phase: The parenchyma of 5 lesions were markedly enhanced in the arterial phase, being isointense or slight hypointense in both the portal venous and delay phases, while 1 lesion was isointense in all phases except being slight hyperintense in the arterial phase; The central scar of 5 lesions were not enhanced in the dynamic phase, but showed delayed enhancement. ②The hepatobiliary (excretory) phase: The parenchyma of all 6 lesions were slight hyperintense or isointense, and tree-like bile ducts with hyperintensity were seen within one lesion. The scar showed no enhancement. ③Pathology: The parenchyma was consisted of disarranged normal hepatocytes but with cytoedema, lack of portal tracts and cholestatic change. The central scar showed rich fibrous tissue, a very thickwalled arteriole, proliferative bile ducts, infiltration of inflammatory cells and myxomatous changes. Conclusion As a dual-phase MR contrast agent capable of depicting both the hemodynamic attributes and hepatobiliary excretion,Gd BOPTA enhanced MRI can reflect the pathological features of FNH and reach a high diagnostic accuracy.
出处 《中国普外基础与临床杂志》 CAS 2007年第5期598-604,共7页 Chinese Journal of Bases and Clinics In General Surgery
关键词 磁共振成像 造影剂 局灶性结节样增生 肝脏 Magnetic resonance imaging Contrast agent Focal nodular hyperplasia Liver
  • 相关文献

参考文献17

二级参考文献54

  • 1李世杰,叶慧义,杜静波,胡广忠,马书亮,张德秀.肝脏局灶结节性增生的CT、MRI诊断[J].中国医学影像学杂志,2004,12(5):344-347. 被引量:19
  • 2邬颖华,宋彬,徐隽,印隆林,毛芸.VIBE序列在原发性肝癌MRI诊断中的价值[J].中国普外基础与临床杂志,2005,12(2):184-187. 被引量:11
  • 3黄俊,李斌奎,元云飞,崔伯康,李锦清,张亚奇,李国辉.肝脏局灶性结节性增生38例临床分析并文献复习[J].癌症,2005,24(10):1241-1245. 被引量:14
  • 4Kehagias D, Moulopoulos, Antoniou A, et al. Focal nodular hyperplasia: imaging findings. Eru Radiol, 2001, 11:202
  • 5Cherqui D, Rahmouni A, Charlotte F,et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young 41 patients with clinical, radiological, and pathological correlations. Hepatology, 1995,22:1674
  • 6Kacl GM, Hagspiel KD, Marinck B, et al. Focal nodular hyperplasia of the liver: serial MRI with Gd-DTPA, superparamagnetic iron oxide and Gd-EOB-DTPA. Abdom-lmaging. 1997, 22:264
  • 7Grazioli-L, Kirchin-M, Pirovano-G, et al. Multihance in the dynamic phase of contrast enhancement: a pictorial assessment. JCAT, 1999,23:61
  • 8Poeckler-Schoeniger C, Koepke J, Gueckel F, et al. MRI with superparamagnetic iron oxide: efficacy in the detection and characterization of focal hepatic lesions. Magn-Reson-Imaging, 1999, 17:383
  • 9Shirkhoda A,Farah MC,Bernacki E,et al.Hepatic focal nodular hyperplasia:CT and sonographic spectrum.Abdom Imagiong,1994,19:34
  • 10Vilgrain V,Flejou JF,Arrive L,et al.Focal nodular hyperplasia of the liver:MR imaging and pathologic correlation in 37 patients.Radiology,1992,184:699

共引文献116

同被引文献76

  • 1张国福,周康荣,严福华,沈继章,施卫斌,张澍杰,陈财忠,张来.Gd-BOPTA增强MRI对小肝癌的诊断价值[J].临床放射学杂志,2004,23(12):1052-1057. 被引量:12
  • 2张国福,周康荣.双功能对比剂Gd-BOPTA在肝脏的临床应用[J].国外医学(临床放射学分册),2004,27(5):308-311. 被引量:4
  • 3刘敏,凌坚,麦远锋,邹齐慧,潘希敏,周翔平.恶性肝肿瘤钆贝葡胺MR增强延迟扫描表现[J].影像诊断与介入放射学,2006,15(2):67-69. 被引量:3
  • 4丁红,王文平,黄备建,李超伦,张晖,魏瑞雪.超声造影检测和诊断小肝癌的价值[J].中国普外基础与临床杂志,2007,14(1):28-31. 被引量:35
  • 5Gallez B, Bacic G, Swartz HM. Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP [J]. Magn Reson Med, 1996; 35(1): 14-19.
  • 6Petersein J, Spinazzi A, Giovagnoni A, et al. Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging-a multicenter phase Ⅲ clinical study[J].Radiology, 2000; 215(3): 727- 736.
  • 7Pirovano G, Vanzulli A, Marti Bonmati L, et al. Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions[J]. AJR Am J Roentgenol, 2000; 175(4): 1111- 1120.
  • 8Helmberger T, Semelka RC. New contrasl agents for imaging the liver [J].Magn Reson Imaging Clin N Am, 2001,9 (4) : 745-766.
  • 9Grazioli L, Morana G, Federle MP, etal. Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine [J]. Radiology, 2001,221(3):731-739.
  • 10del Frate C, Bazzocchi M, Mortele KJ, et al. Detection of liver metastases: comparison of gadobenate dimeglun, ine enhanced and ferumoxides-enhanced MR imaging examinations[J].Radiology, 2002; 225(3): 766-772.

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部